07 Nov 2016 --- Patients with malignant melanoma that has spread are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria, according to new research presented at the National Cancer Research Institute’s (NCRI) Cancer Conference in Liverpool.
